Herpes 2, formally called herpes simplex virus type 2 (HSV-2), is a lifelong viral infection that primarily causes genital herpes. An estimated 520 million people aged 15 to 49 worldwide carry HSV-2, making it one of the most common sexually transmitted infections on the planet. Of those, roughly 205 million experienced at least one symptomatic episode in 2020, meaning a large portion of carriers never realize they’re infected.
How HSV-2 Infects the Body
HSV-2 is a double-stranded DNA virus wrapped in multiple protective layers, including an outer envelope studded with proteins that help it latch onto human cells. When the virus reaches skin or mucous membranes, four of these surface proteins work together to bind to receptors on epithelial cells (the cells lining your skin and genital tissue) and release viral contents inside.
Once inside, the virus replicates quickly and spreads from cell to cell using the same junction proteins your own cells use to stay connected. This trick helps HSV-2 move through tissue while largely avoiding detection by the immune system. After the initial infection clears from the surface, the virus travels along nerve fibers to clusters of nerve cells near the base of the spine, where it goes dormant. It can reactivate at any point, traveling back down the nerve to the skin’s surface to cause a new outbreak or to shed invisibly without symptoms.
Symptoms of a First Outbreak
A first episode of genital HSV-2 is typically the most severe. It can cause painful ulcers or blisters on the genitals, buttocks, or thighs, sometimes accompanied by flu-like symptoms: fever, body aches, and swollen lymph nodes. According to the CDC, newly acquired genital herpes can produce prolonged illness with severe genital ulcerations and even neurologic involvement in some cases. That first outbreak can last an average of about 10 days, though it sometimes stretches to a month.
Many people, however, have a first episode so mild they don’t notice it at all. The classic painful, fluid-filled blisters that most people associate with herpes are absent in a significant number of infected individuals at the time they’re evaluated. This is a major reason so many people carry HSV-2 without knowing it.
Recurrent Outbreaks Over Time
Nearly all people with a symptomatic first episode of HSV-2 will have recurrences. The good news is that outbreaks generally become shorter and less frequent over time. In the first year after an initial episode, recurrences average about 10 days. For people one to nine years out, that drops to around 7 days, and after a decade it averages about 6.5 days. The body’s immune response gradually gets better at suppressing the virus, though it never eliminates it entirely.
Between visible outbreaks, HSV-2 can still shed from the skin’s surface without causing any symptoms. This asymptomatic shedding occurs even in people who haven’t had a noticeable outbreak in years, which is why transmission often happens when neither partner realizes the virus is active.
How HSV-2 Spreads
HSV-2 spreads through direct skin-to-skin contact during vaginal, anal, or oral sex. It can transmit during visible outbreaks or during the silent shedding periods described above. You don’t need to see sores to be at risk of catching or passing the virus.
Consistent condom use significantly reduces transmission, though protection isn’t equal in both directions. A study in Clinical Infectious Diseases found that condoms reduced per-act transmission from men to women by 96%, but from women to men by a more modest 65%. The difference likely reflects the fact that condoms cover most of the skin that sheds virus in men but don’t fully cover all potentially exposed skin in either partner.
Testing and Diagnosis
If you have active sores, a healthcare provider can swab the lesion and test for the virus directly. When no sores are present, a blood test that detects type-specific antibodies (IgG) can confirm whether you carry HSV-2.
Timing matters. IgG antibodies don’t reliably appear until at least two weeks after infection, and many clinicians recommend waiting even longer (up to 12 weeks) for the most reliable results. Even then, blood tests for HSV-2 aren’t perfect. ELISA-based IgG tests have a sensitivity of about 92%, meaning they catch most infections, but specificity can be as low as 57%, which means false positives are a real concern. A positive screening result on a standard blood test sometimes needs confirmation with a more specific test, especially in people with no symptoms and no known exposure.
Treatment Options
There is no cure for HSV-2, but antiviral medications effectively manage outbreaks and reduce transmission risk. Treatment falls into two strategies. Episodic therapy means taking antiviral medication at the first sign of an outbreak to shorten its duration and severity. Suppressive therapy means taking a daily antiviral to reduce the frequency of outbreaks and lower the risk of passing the virus to a partner.
Both approaches use the same class of antiviral drugs, which work by blocking the virus’s ability to replicate. Most people tolerate these medications well and can take them safely for years. Your doctor can help decide which approach makes more sense based on how often you experience outbreaks and whether you’re in a relationship with someone who doesn’t carry the virus.
Potential Complications
Increased HIV Risk
HSV-2 creates breaks in the skin and triggers a local immune response that, paradoxically, makes it easier for HIV to enter the body. Research from a longitudinal study in South Africa found that HSV-2 infection in either partner tripled the per-act risk of HIV transmission. This makes HSV-2 management an important part of broader sexual health, particularly in areas where HIV prevalence is high.
Risks During Pregnancy
Neonatal herpes, while rare, is the most serious complication of HSV-2 in pregnancy. The risk depends heavily on when the mother acquired the virus. A new (primary) HSV infection during pregnancy carries roughly a 50% chance of transmitting the virus to the baby during vaginal delivery. For women with a recurrent infection (meaning they had the virus before pregnancy), that risk drops to less than 3%. This is because the mother’s immune system has already produced antibodies that cross the placenta and offer the baby some protection. Providers typically assess the situation near the due date and may recommend a cesarean delivery if active lesions are present.
Living With HSV-2
For most people, HSV-2 is a manageable condition rather than a dangerous one. Outbreaks become less frequent and shorter with time. Daily suppressive therapy can further reduce outbreak frequency and cut transmission risk substantially. Condoms add another significant layer of protection.
The psychological impact of a diagnosis often outweighs the physical symptoms. Understanding the actual numbers, that over half a billion people carry this virus and that effective tools exist to manage it and reduce transmission, can help put the diagnosis in perspective.